On 3 November 2009, the MHRA issued additional safety information for this product. A Europe-wide review of clinical trial data, adverse drug reaction reports and published literature on statins has concluded that any of the following adverse reactions may be associated with statin use: sleep disturbances, memory loss, sexual dysfunction, depression and interstitial lung disease (leading to breathing problems). Product information for all statins will be updated with warnings on all of these side effects.

Further information can be found on the MHRA website.